Menu
GeneBe

MEGF10

multiple EGF like domains 10, the group of Scavenger receptors

Basic information

Region (hg38): 5:127290795-127465737

Links

ENSG00000145794NCBI:84466OMIM:612453HGNC:29634Uniprot:Q96KG7AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • MEGF10-related myopathy (Definitive), mode of inheritance: AR
  • MEGF10-related myopathy (Strong), mode of inheritance: AR
  • MEGF10-related myopathy (Supportive), mode of inheritance: AR
  • MEGF10-related myopathy (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Congenital myopathy 10A, severe variant; Congenital myopathy 10B, mild variantARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Musculoskeletal17236770; 22101682; 22371254; 23453856; 27460346; 36349186

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MEGF10 gene.

  • MEGF10-related myopathy (804 variants)
  • not provided (209 variants)
  • not specified (53 variants)
  • Inborn genetic diseases (44 variants)
  • Congenital myopathy 10b, mild variant (4 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MEGF10 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
11
clinvar
128
clinvar
5
clinvar
144
missense
1
clinvar
3
clinvar
394
clinvar
4
clinvar
3
clinvar
405
nonsense
11
clinvar
4
clinvar
15
start loss
1
clinvar
1
frameshift
5
clinvar
2
clinvar
7
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
13
clinvar
1
clinvar
14
splice region
9
24
2
35
non coding
87
clinvar
144
clinvar
44
clinvar
275
Total 17 22 495 276 52

Highest pathogenic variant AF is 0.0000197

Variants in MEGF10

This is a list of pathogenic ClinVar variants found in the MEGF10 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
5-127290856-G-T MEGF10-related myopathy Uncertain significance (Jan 13, 2018)904033
5-127290878-T-C MEGF10-related myopathy Uncertain significance (Jan 13, 2018)350630
5-127290923-A-G MEGF10-related myopathy Uncertain significance (Mar 02, 2018)904034
5-127290953-G-A MEGF10-related myopathy Benign (Jul 03, 2018)350631
5-127290979-A-C MEGF10-related myopathy Uncertain significance (Jan 13, 2018)350632
5-127299745-GT-G Benign (May 29, 2020)1233494
5-127299975-G-C Benign (Jul 03, 2018)1295222
5-127299983-A-T Likely benign (Jun 05, 2018)669208
5-127299989-A-G not specified Likely benign (Apr 18, 2016)384858
5-127299999-A-G not specified • MEGF10-related myopathy Benign/Likely benign (Sep 12, 2017)385504
5-127300033-C-T not specified Likely benign (Aug 23, 2016)388583
5-127300052-T-G MEGF10-related myopathy Uncertain significance (Feb 16, 2018)904035
5-127331112-A-G Likely benign (Jun 18, 2018)672379
5-127331273-A-AT Likely benign (Feb 02, 2021)1188266
5-127331280-C-T MEGF10-related myopathy Conflicting classifications of pathogenicity (Apr 15, 2019)350634
5-127331302-G-A not specified Likely benign (Mar 21, 2016)384416
5-127331311-G-T MEGF10-related myopathy Uncertain significance (Apr 23, 2022)2129496
5-127331323-G-A Likely benign (Mar 29, 2018)739012
5-127331327-T-C Inborn genetic diseases Uncertain significance (Sep 13, 2023)2623086
5-127331350-A-G MEGF10-related myopathy Likely benign (Aug 04, 2023)1161564
5-127331358-G-A MEGF10-related myopathy Conflicting classifications of pathogenicity (Sep 01, 2023)539961
5-127331359-C-T MEGF10-related myopathy Likely benign (Jul 09, 2022)1673668
5-127331367-T-C not specified • MEGF10-related myopathy Conflicting classifications of pathogenicity (Aug 15, 2022)379372
5-127331374-A-G MEGF10-related myopathy Likely benign (Jan 12, 2021)1580656
5-127331376-C-A MEGF10-related myopathy Uncertain significance (Jul 30, 2022)2122164

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MEGF10protein_codingprotein_codingENST00000274473 24174907
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.3900.6101256740741257480.000294
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.056086850.8870.00003947497
Missense in Polyphen187259.050.721872798
Synonymous0.7582392540.9400.00001622096
Loss of Function5.851566.50.2260.00000344766

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005300.000530
Ashkenazi Jewish0.000.00
East Asian0.001140.00114
Finnish0.000.00
European (Non-Finnish)0.0002390.000237
Middle Eastern0.001140.00114
South Asian0.0002960.000294
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Membrane receptor involved in phagocytosis by macrophages and astrocytes of apoptotic cells. Receptor for C1q, an eat-me signal, that binds phosphatidylserine expressed on the surface of apoptotic cells (PubMed:27170117). Cooperates with ABCA1 within the process of engulfment. Promotes the formation of large intracellular vacuoles and may be responsible for the uptake of amyloid-beta peptides (PubMed:20828568, PubMed:17643423). Necessary for astrocyte-dependent apoptotic neuron clearance in the developing cerebellum (PubMed:27170117). Plays role in muscle cell proliferation, adhesion and motility. Is also an essential factor in the regulation of myogenesis. Controls the balance between skeletal muscle satellite cells proliferation and differentiation through regulation of the notch signaling pathway (PubMed:28498977). May also function in the mosaic spacing of specific neuron subtypes in the retina through homotypic retinal neuron repulsion. Mosaics provide a mechanism to distribute each cell type evenly across the retina, ensuring that all parts of the visual field have access to a full set of processing elements (PubMed:17498693, PubMed:17643423, PubMed:20828568, PubMed:22101682, PubMed:27170117, PubMed:28498977). {ECO:0000269|PubMed:17205124, ECO:0000269|PubMed:17498693, ECO:0000269|PubMed:17643423, ECO:0000269|PubMed:20828568, ECO:0000269|PubMed:22101682, ECO:0000269|PubMed:27170117, ECO:0000269|PubMed:28498977}.;
Disease
DISEASE: Myopathy, early-onset, areflexia, respiratory distress, and dysphagia (EMARDD) [MIM:614399]: An autosomal recessive congenital myopathy characterized by onset at birth, or early in infancy, of respiratory distress caused by diaphragmatic weakness. Additional features are dysphagia resulting in poor feeding, failure to thrive, poor head control, facial weakness, cleft palate, contractures and scoliosis. Affected individuals become ventilator-dependent, and most require feeding by gastrostomy. The disorder results in severe muscle weakness and most patients never achieve walking. Death from respiratory failure in childhood occurs in about half of patients. Muscle biopsies from affected individuals show myopathic changes, replacement of myofibers with fatty tissue, small and incompletely fused muscle fibers, and variation in fiber size. Short regions of sarcomeric disorganization with few or no mitochondria (minicores) have been observed in some cases. {ECO:0000269|PubMed:22101682, ECO:0000269|PubMed:22371254, ECO:0000269|PubMed:23954233, ECO:0000269|PubMed:27170117, ECO:0000269|PubMed:28498977}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.124

Intolerance Scores

loftool
0.476
rvis_EVS
-1.21
rvis_percentile_EVS
5.72

Haploinsufficiency Scores

pHI
0.0906
hipred
Y
hipred_score
0.605
ghis
0.598

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.262

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Megf10
Phenotype
cellular phenotype; vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);

Zebrafish Information Network

Gene name
megf10
Affected structure
muscle
Phenotype tag
abnormal
Phenotype quality
disorganized

Gene ontology

Biological process
receptor-mediated endocytosis;skeletal muscle satellite cell activation;skeletal muscle satellite cell differentiation;skeletal muscle satellite cell proliferation;muscle cell proliferation;homotypic cell-cell adhesion;engulfment of apoptotic cell;recognition of apoptotic cell;regulation of skeletal muscle tissue development;regulation of muscle cell differentiation;myoblast migration;muscle cell development;apoptotic process involved in development
Cellular component
phagocytic cup;plasma membrane;integral component of membrane;cell projection
Molecular function
complement component C1q binding;scavenger receptor activity;Notch binding